Increased plasma glutamic acid in a genetic model of epilepsy.
A significant increase in the plasma levels of glutamic acid and a significant decrease in aspartic acid and taurine in epileptic patients and their first degree relatives was reported more than a decade ago and an underlying genetic basis for these amino acid changes was suggested. The main objective of the present study was to determine the plasma levels of glutamic acid, aspartic acid and taurine in El mice which are an inbred epileptic mutant mouse strain. The results show a significant increase in plasma glutamic acid but no changes in aspartic acid or taurine in the epileptic mice as compared to controls. The data provide the first evidence of a significant increase in plasma glutamic acid in an animal model of hereditary epilepsy and substantiate the hypothesis that a genetic defect underlies the elevated plasma glutamic acid levels in association with epilepsy. The findings are also compatible with neurochemical and neurophysiological evidence implicating glutamic acid in the mechanism of seizures.
Department of Neurochemistry, Okayama University Medical School, Japan.
N A
NA
Janjua
H
H
Kabuto
A
A
Mori
D000818:Animals; D001224:Aspartic Acid / Q000097:blood*; D004198:Disease Susceptibility; D004830:Epilepsy, Tonic-Clonic / Q000097:blood* / Q000235:genetics; D005971:Glutamates / Q000097:blood*; D018698:Glutamic Acid; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008957:Models, Genetic; D013654:Taurine / Q000097:blood*
D005971:Glutamates; D013654:Taurine; D001224:Aspartic Acid; D018698:Glutamic Acid